Diabetes Mellitus and diabetic ketoacidosis associated with pembrolizumab
Diabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus (DM) and is characterized by hyperglycemia, hyperketonemia and metabolic acidosis. With the increasing use of immune checkpoint inhibitors (ICIs), such as pembrolizumab in cancer therapy, it’s important tound...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Hrvatski liječnički zbor
2023-01-01
|
| Sarja: | Liječnički vjesnik |
| Aiheet: | |
| Linkit: | https://hrcak.srce.hr/file/437681 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|